| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Revenue | $11.7B | $11.8B | $12.0B | $12.0B | $9.3B | $5.4B | $2.2B | $2.0B |
| Cost of Revenue | — | — | — | — | — | — | — | — |
| Gross Profit | — | — | — | — | — | — | — | — |
| R&D Expense | — | — | — | — | — | — | — | — |
| SG&A Expense | $1.4B | $1.4B | $1.4B | $1.3B | $1.1B | $0.7B | $1.2B | $1.2B |
| Operating Income | — | — | — | — | — | — | — | — |
| Net Income | $-0.9B | $-1.8B | $1.6B | $2.8B | $1.3B | $-0.7B | $0.1B | $0.0B |
| EPS (Basic) | $-25.25 | $-51.23 | $42.57 | $58.41 | $19.79 | $-9.71 | $1.92 | $0.16 |
| EPS (Diluted) | $-25.25 | $-51.23 | $42.08 | $57.16 | $19.44 | $-9.71 | $1.90 | $0.16 |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $31.3B | $29.0B | $32.6B | $25.9B | $22.6B | $17.5B | $23.1B | $19.1B |
| Current Assets | $2.1B | $2.0B | $2.1B | $1.9B | $1.8B | $1.8B | $2.1B | $2.2B |
| Cash & Equivalents | $0.5B | $0.5B | $0.6B | $0.6B | $0.5B | $0.7B | $0.7B | $0.6B |
| Total Liabilities | — | — | — | — | — | — | — | — |
| Current Liabilities | $2.9B | $2.7B | $2.7B | $2.6B | $2.4B | $2.1B | $2.2B | $1.7B |
| Stockholders' Equity | $-3.1B | $-2.3B | $-0.3B | $-0.7B | $-0.2B | — | — | — |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $3.3B | $3.5B | $3.8B | $4.7B | $3.5B | $0.7B | $2.6B | $2.6B |
| Investing Cash Flow | $-5.2B | $-2.8B | $-7.3B | $-4.3B | $-6.3B | $3.2B | $-2.8B | $-3.4B |
| Capital Expenditures | — | — | — | — | — | — | — | — |
| Financing Cash Flow | $1.9B | $-0.8B | $3.5B | $-0.4B | $2.7B | $-4.0B | $0.3B | $0.7B |